An Study to Compare Single-dose Pharmacokinetic and Pharmacodynamic Characteristics of Epogen® and Epoetin Alfas (Eprex® and Binocrit®) in Healthy Subjects.

Trial Identifier:	D5740C00003
Sponsor:	AstraZeneca
Start Date:	June 2018
Primary Completion Date:	November 2018
Condition:	Anemia; Chronic Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Translation
	German Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Germany	Berlin, Germany, 14050

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.